1. Home
  2. SHOO vs VERA Comparison

SHOO vs VERA Comparison

Compare SHOO & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$31.35

Market Cap

2.7B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$39.96

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
VERA
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SHOO
VERA
Price
$31.35
$39.96
Analyst Decision
Buy
Strong Buy
Analyst Count
7
10
Target Price
$42.43
$81.30
AVG Volume (30 Days)
1.4M
968.6K
Earning Date
05-28-2026
05-27-2026
Dividend Yield
2.58%
N/A
EPS Growth
N/A
N/A
EPS
0.63
N/A
Revenue
$2,534,109,000.00
N/A
Revenue This Year
$12.27
N/A
Revenue Next Year
$5.87
$445.28
P/E Ratio
$51.82
N/A
Revenue Growth
11.00
N/A
52 Week Low
$19.05
$18.53
52 Week High
$46.88
$56.05

Technical Indicators

Market Signals
Indicator
SHOO
VERA
Relative Strength Index (RSI) 27.97 42.61
Support Level $23.21 $19.84
Resistance Level $35.98 $56.05
Average True Range (ATR) 1.60 2.29
MACD -0.24 0.16
Stochastic Oscillator 0.72 39.02

Price Performance

Historical Comparison
SHOO
VERA

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: